Ameriprise’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $886K | Sell |
42,295
-234,632
| -85% | -$5.28M | ﹤0.01% | 3355 |
|
|
2025
Q4 | $6.37M | Buy |
276,927
+138,243
| +100% | +$4.55M | ﹤0.01% | 2261 |
|
|
2025
Q3 | $4.17M | Buy |
138,684
+29,447
| +27% | +$883K | ﹤0.01% | 2564 |
|
|
2025
Q2 | $3.97M | Buy |
109,237
+89,940
| +466% | +$3.24M | ﹤0.01% | 2531 |
|
|
2025
Q1 | $699K | Buy |
19,297
+5,901
| +44% | +$245K | ﹤0.01% | 3368 |
|
|
2024
Q4 | $564K | Buy |
13,396
+1,039
| +8% | +$51.5K | ﹤0.01% | 3483 |
|
|
2024
Q3 | $686K | Buy |
12,357
+578
| +5% | +$29.4K | ﹤0.01% | 3370 |
|
|
2024
Q2 | $484K | Sell |
11,779
-1,889
| -14% | -$80.7K | ﹤0.01% | 3420 |
|
|
2024
Q1 | $638K | Buy |
13,668
+2,592
| +23% | +$122K | ﹤0.01% | 3339 |
|
|
2023
Q4 | $530K | Sell |
11,076
-4,417
| -29% | -$171K | ﹤0.01% | 3435 |
|
|
2023
Q3 | $552K | Sell |
15,493
-5,227
| -25% | -$207K | ﹤0.01% | 3372 |
|
|
2023
Q2 | $956K | Sell |
20,720
-37,775
| -65% | -$1.75M | ﹤0.01% | 3192 |
|
|
2023
Q1 | $2.35M | Buy |
58,495
+20,312
| +53% | +$872K | ﹤0.01% | 2769 |
|
|
2022
Q4 | $1.77M | Buy |
38,183
+22,092
| +137% | +$869K | ﹤0.01% | 2864 |
|
|
2022
Q3 | $667K | Buy |
16,091
+1,508
| +10% | +$77.5K | ﹤0.01% | 3287 |
|
|
2022
Q2 | $870K | Buy |
14,583
+10
| +0.1% | +$615 | ﹤0.01% | 3176 |
|
|
2022
Q1 | $1.06M | Sell |
14,573
-346
| -2% | -$24.1K | ﹤0.01% | 3192 |
|
|
2021
Q4 | $1.25M | Buy |
14,919
+224
| +2% | +$18.2K | ﹤0.01% | 3151 |
|
|
2021
Q3 | $1.33M | Sell |
14,695
-10,365
| -41% | -$937K | ﹤0.01% | 3036 |
|
|
2021
Q2 | $2.39M | Buy |
25,060
+848
| +4% | +$88.3K | ﹤0.01% | 2855 |
|
|
2021
Q1 | $2.75M | Sell |
24,212
-16,714
| -41% | -$2.28M | ﹤0.01% | 2729 |
|
|
2020
Q4 | $5.67M | Buy |
40,926
+17,730
| +76% | +$2.1M | ﹤0.01% | 2178 |
|
|
2020
Q3 | $1.91M | Buy |
23,196
+3,529
| +18% | +$293K | ﹤0.01% | 2695 |
|
|
2020
Q2 | $1.54M | Sell |
19,667
-6,420
| -25% | -$425K | ﹤0.01% | 2730 |
|
|
2020
Q1 | $1.16M | Buy |
26,087
+16,635
| +176% | +$864K | ﹤0.01% | 2756 |
|
|
2019
Q4 | $402K | Sell |
9,452
-892,376
| -99% | -$36.8M | ﹤0.01% | 3407 |
|
|
2019
Q3 | $38.6M | Sell |
901,828
-15,797
| -2% | -$858K | 0.02% | 782 |
|
|
2019
Q2 | $58.3M | Buy |
917,625
+89,865
| +11% | +$5.72M | 0.03% | 605 |
|
|
2019
Q1 | $57.4M | Sell |
827,760
-18,712
| -2% | -$1.07M | 0.03% | 593 |
|
|
2018
Q4 | $36.8M | Sell |
846,472
-385,801
| -31% | -$21.1M | 0.02% | 744 |
|
|
2018
Q3 | $94.1M | Sell |
1,232,273
-99,189
| -7% | -$8.07M | 0.03% | 492 |
|
|
2018
Q2 | $102M | Buy |
1,331,462
+132,431
| +11% | +$8.55M | 0.05% | 406 |
|
|
2018
Q1 | $61.1M | Buy |
1,199,031
+1,161,985
| +3,137% | +$58.5M | 0.03% | 560 |
|
|
2017
Q4 | $1.72M | Sell |
37,046
-9,517
| -20% | -$467K | ﹤0.01% | 2732 |
|
|
2017
Q3 | $2.48M | Sell |
46,563
-55,211
| -54% | -$3.27M | ﹤0.01% | 2501 |
|
|
2017
Q2 | $6.32M | Buy |
101,774
+7,229
| +8% | +$436K | ﹤0.01% | 1899 |
|
|
2017
Q1 | $6.41M | Sell |
94,545
-13,566
| -13% | -$1.03M | ﹤0.01% | 1853 |
|
|
2016
Q4 | $7.6M | Sell |
108,111
-65,708
| -38% | -$4.66M | ﹤0.01% | 1714 |
|
|
2016
Q3 | $12.3M | Sell |
173,819
-175,434
| -50% | -$11.2M | 0.01% | 1286 |
|
|
2016
Q2 | $17.1M | Buy |
349,253
+139,511
| +67% | +$9.02M | 0.01% | 1003 |
|
|
2016
Q1 | $13.3M | Sell |
209,742
-260,592
| -55% | -$17.1M | 0.01% | 1207 |
|
|
2015
Q4 | $52.8M | Buy |
470,334
+93,380
| +25% | +$9.34M | 0.03% | 454 |
|
|
2015
Q3 | $36.3M | Buy |
376,954
+264,457
| +235% | +$30.3M | 0.02% | 611 |
|
|
2015
Q2 | $11.5M | Buy |
112,497
+62,197
| +124% | +$4.83M | 0.01% | 1465 |
|
|
2015
Q1 | $3.12M | Buy |
50,300
+25,546
| +103% | +$1.42M | ﹤0.01% | 2360 |
|
|
2014
Q4 | $1.09M | Sell |
24,754
-21,547
| -47% | -$987K | ﹤0.01% | 2846 |
|
|
2014
Q3 | $2.62M | Sell |
46,301
-64,689
| -58% | -$3.26M | ﹤0.01% | 2385 |
|
|
2014
Q2 | $4.98M | Sell |
110,990
-49,543
| -31% | -$2.04M | ﹤0.01% | 2083 |
|
|
2014
Q1 | $7.85M | Buy |
+160,533
| New | +$8.26M | ﹤0.01% | 1713 |
|
Other funds holding RARE
VPM
VCM
RI
SI
BG
Ameriprise's RARE Position: Q1 2026 in Review
Ameriprise reduced its Ultragenyx Pharmaceutical (RARE) stake by 85% in Q1 2026, selling an estimated $5.28M and leaving 42,295 shares worth $886K. The position accounts for ﹤0.01% of the portfolio, ranked #3355.
Ameriprise first reported a position in RARE in Q1 2014 and has held it in 49 quarters since. The position peaked at $102M in Q2 2018. 295 funds tracked by Wall St. Rank hold RARE as of Q1 2026.
- Ameriprise held 42,295 shares of Ultragenyx Pharmaceutical worth $886K as of Q1 2026.
- Ameriprise sold 234,632 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $5.28M.
- Ultragenyx Pharmaceutical made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3355 holding.
- Ameriprise first reported a position in Ultragenyx Pharmaceutical in Q1 2014 and has held it in 49 quarters since.
- Ameriprise's Ultragenyx Pharmaceutical position peaked at $102M in Q2 2018.
- 295 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.